Boston Medical Center's losses come at a bad time, with looming Medicaid cuts
Gary Young says that while BMC is having cash flow issues, they won't fail as a bastion of the research and care.
News
Showing items tagged with
57 Members
-
The Boston Globe -
D'Amore-McKim faculty member receives Fulbright
Northeastern Global NewsAs part of his semester in Canada, Anand Nair plans to develop and test an AI-enabled remote patient monitoring system.
-
D'Amore-McKim School of Business Hosts Discussion on Partnership Models Driving Global Life-Sciences Innovation
On Tuesday, April 7, D'Amore-McKim School of Business professors Valentina Marano, Ravi Ramamurti, and Gary Young convened academic and industry leaders for a panel discussion on the partnership models driving innovation across the global life-sciences ecosystem.
-
When healthcare costs climb, business strategies shift
As healthcare costs surge, companies are rethinking how they invest, hire, and grow. Rising benefit expenses are reshaping business strategies, driving innovation in cost management, and forcing employers to balance competitiveness with financial sustainability.
-
Why Retail Health Clinics Failed
Harvard Buisness ReviewA number of retail chains that have been trying to move into primary care have been retrenching or withdrawing altogether. Despite their struggles, D'Amore-McKim Professor Timothy Hoff, says that there is still a place for retail chains in health care.
-
Reversing the Innovation Pathway Could Be the Key to Cost-Efficient Health Care
Reversing the Innovation Pathway Could Be the Key to Cost-Efficient Health CareIt seems axiomatic that innovation happens in economies where resources are plentiful, but it is equally true that necessity is the mother of invention, so can new ideas that could transform health care delivery in the developed world arise in low-resource regions?
-
Full-body MRIs are the latest celebrity-endorsed health craze. Will they save your life?
Gary J. Young says that the full body MRI trend is not just about the astronomical costs to individuals but about the additional strain on a system that already relies too heavily on imaging and not enough on preventative measures.
-
Health Care in Sub-Saharan Africa: 21st Century Trends and Forecasts
The future of health in Sub-Saharan Africa is both uncertain and promising. Life expectancy in this region has increased significantly, and growing economies may provide opportunities for increased financing for health. To effectively improve health in Sub-Saharan Africa, deliberate political investments and African-led models are necessary, as well as robust health systems that can adapt to changing disease and demographic patterns. Community health workers will play a crucial role in achieving universal health coverage and combating pandemics. However, Sub-Saharan Africa remains reliant on foreign financing and must combat corruption and improve domestic health governance to achieve autonomy. Ultimately, interventions to improve health in the region must target the population's changing needs and infrastructure demands.
-
Eli Lilly's 70% price drop on insulin is the ‘tip of the iceberg' in fight to lower drug costs, Northeastern expert says
Gary Young, director of Northeastern University's Center for Health Policy and Healthcare Research, professor of strategic management and healthcare systems, says insulin has become “a lightning rod” for concerns about rising drug costs. But Eli Lilly's decision is only the latest move in the fight to lower drug costs.
-
Are charitable food donations a double-edged sword? Donations reduce food waste, but also increase food prices
Northeastern business professor John Lowrey recently published a paper stating that donation of perishables improves stores' profitability by making room for more appealing—and higher priced products—and drawing discerning rather than price-conscious shoppers.
-
Will the COVID-19 vaccine become an annual dose like the flu shot? How will it work?
The U.S. Food and Drug Administration is considering a major change in the way COVID-19 vaccines and boosters are given. Northeastern experts say it would streamline the process for the public and suppliers.